Search CORE

10 research outputs found

Sumatriptan has no clinically relevant effect in the treatment of episodic tension-type headache

Initial human experience with MK-462 (rizatriptan): a novel 5=HT ID

Sumatriptan Injection is Superior to Placebo in The Acute Treatment of Migraine With Regard to Both Efficacy and General Well-Being

Author: AL Toth
C Dahlöf
C Edwards
Dahlöf C
Dimenäs E
Headache Classification Committee of the International Headache Society.
Peatfield RC
The Oral Sumatriptan Dose-Defining Study Group.
Thrush D
Publication venue: 'Wiley'
Publication date
Field of study

Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment

Author: A Rapoport
AM Rapoport
C Dahlöf
C Dahlöf
CG Dahlöf
F Sheftell
H Gijsmant
H Havanka
J Olesen
J Pascual
JG Edmeads
KA Petersen
KM Connor
MD Ferrari
NT Mathew
P Tfelt-Hansen
P Tfelt-Hansen
P Tfelt-Hansen
P Tfelt-Hansen
P Tfelt-Hansen
P Tfelt-Hansen
P Tfelt-Hansen
Peer Tfelt-Hansen
PJ Goadsby
PJ Goadsby
PR Saxena
R Salonen
R Stark
RK Cady
Sumatriptan—an oral dose-defining study. The Oral Sumatriptan Dose-Defining Study Group
The Subcutaneous Sumatriptan International Study Group
TW Ho
TW Ho
V Pfaffenrath
WH Visser
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

Headache: Experience with Large Multicenter Trials in the Treatment of Migraine Attacks

Author: A Pilgrim
A Reches
AJ Pilgrim
AM Rapoport
AM Rapoport
BK Rasmussen
C Dahlöf
CN Perry
G Rederich
GL Plosker
H Göbel
H Massiou
Headache Classification Committee of the International Headache Society
J Brennum
J Klapper
J Touchon
K Jensen
KJ Palmer
M Asgharnejad
M Dooley
M Kramer
M Wizkinson
MB Russel
MD Ferrari
Multinational Oral sumatriptan and Cafergot Comparative Study Group
NS Gunasekara
NT Mathew
Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study group
Oral Sumatriptan Dose-defining study Group
P Tfelt-Hansen
P Tfelt-Hansen
P Tfelt-Hansen
P Tfelt-Hansen
P Tfelt-Hansen
P Tfelt-Hansen
P Tfelt-Hansen
P Tfelt-Hansen
P Winner
PE Rolan
PJ Goadsby
PPA Humphrey
PR Saxena
R Jensen
R Salonen
RK Cady
RK Cady
Subcutaneous Sumatriptan International Study Group
The Diclofenac-K/Sumatriptan Migraine Study Group
TJ Steiner
VV Myllylä
WF Stewart
WH Visser
Publication venue: 'Springer Science and Business Media LLC'
Publication date: 01/01/2001
Field of study

Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. A comment

Author: A. Klassen
C. Dahlöf
E. Sternieri
G.N. Volans
H. Havanka
H.E. Connor
International Headache Society Clinical Trial Subcommittee
L.F. Lacey
L.L. Thomsen
M.D. Ferrari
N.T. Mathew
N.T. Mathew
Oral Sumatriptan Dose Defining Study Group
P. Tfelt-Hansen
P. Tfelt-Hansen
P. Tfelt-Hansen
P.P. Humphrey
P.R. Saxena
Peer Tfelt-Hansen
S.S. Jhee
Sumatriptan Cluster Headache Study Group
W.H. Visser
W.H. Visser
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

OCT1 mediates hepatic uptake of sumatriptan and loss-of-function OCT1

Author: Ahlin
Bourdet
Cady
Cameron
Chen
Derry
Diener
Dixon
Dixon
Dodick
Evans
Evers
Ferrari
Fowler
Fukuda
Grimsby
Gupta
Hardman
Hendrickx
Hilgendorf
Hu
Huang
Ito
Jensen
Jhee
Kerb
Lacey
Lipton
Marmura
Nies
Roberto
Saadatmand
Saura
Seitz
Shu
Shu
Tfelt-Hansen
The Oral Sumatriptan Dose-Defining Study Group
Tweedie
Tzvetkov
Tzvetkov
Tzvetkov
Tzvetkov
Venkatasubramanian
Wang
World Health Organization
Publication venue: 'Wiley'
Publication date
Field of study

Migraine and Women: Diagnosis, Pathophysiology, and Treatment

Author: American Psychiatric Association
Anthony M
Bille BS
Carstairs LS
Fanchamps A
Friedman M
Friedman MD
Fromm-Reichman F
Headache Classification
Illness Disability Statistics
Kudrow L
Lake AE
Lance JW
Leao AAP
Martin MJ
Moskowitz MA
Pedersen SA
Rapoport AM
Rapoport AM
Rapport MM
Ray BS
Sakai F
Saper JR
Selinsky H
Sicuteri F
The Oral Sumatriptan Dose-Defining Study Group
Volans GN
Yri H GM
Ziegler DK
Publication venue: 'Mary Ann Liebert Inc'
Publication date
Field of study

Überblick zur Rolle der 5-HT3-Rezeptorantagonisten in der Migränetherapie

Author: A Butler
B Scatton
BMT Rowat
BP Richardson
BP Richardson
C Dahlöf
C Loisy
EGM Couturier
F Sicuteri
FD King
GD Pratt
GJ Kilpatrick
GJ Kilpatrick
GJ Sanger
HE Moss
J Giordano
J Giordano
JB Hughes
JH Gaddum
JR Fozard
JR Fozard
JR Fozard
JR Fozard
JR Fozard
JR Fozard
JR Fozard
JW Lance
L Edvinsson
LX Cubeddu
M Anthony
M Ferrari
M Fitzgerald
MA Moskowitz
MA Moskowitz
MD Ferrari
MD Ferrari
MD Ferrari
Patten JP [For the oral sumatriptan dose-defining study group]
PB Bradley
PPA Humphrey
PR Saxena
R Nieuwenhuys
RJ Gralla
SG Griffith
SR Glaum
WW Smith
X Lataste
Publication venue: 'Springer Science and Business Media LLC'
Publication date: 01/01/1994
Field of study

Ten Years of Rizatriptan: From Development to Clinical Science and Future Directions

Author: Adelman
Ahonen
Ahrens
Allen
Block
Bomhof
Brain
Burstein
Burstein
Burstein
Bussone
Buzzi
Cady
Cady
Cady
Christie
Cumberbatch
Cumberbatch
Cumberbatch
Cumberbatch
Cutler
Cutler
Dahlof
Dahlof
Dahlof
Dodick
Dodick
Doods
Doods
Edvinsson
Edvinsson
Evans
Ferrari
Ferrari
Ferrari
Fiore
Gerth
Gijsman
Goadsby
Goadsby
Gobel
Goldberg
Goldstein
Goldstein
Hargreaves
Hargreaves
Hargreaves
Ho
Humphrey
Humphrey
Kolodny
Kramer
Krymchantowski
Krymchantowski
Krymchantowski
Lainez
Levy
Lewis
Lines
Lipton
Loder
Longmore
Longmore
Longmore
Ma
Mannix
Mannix
Mathew
May
Moskowitz
Moskowitz
Moskowitz
Moskowitz
Nilsson
Olesen
Pascual
Pascual
Pascual
Pfaffenrath
Razzaque
Razzaque
Saito
Salvatore
Santanello
Santanello
Santanello
Saxena
Sciberras
Sclar
Shapiro
Shepheard
Shepheard
Shepheard
Silberstein
Silberstein
Silberstein
Smith
Strassman
Swan
Teall
Tepper
Tfelt-Hansen
The Oral Sumatriptan Dose-Defining Study Group
Visser
Visser
Williamson
Williamson
Winner
Publication venue: 'Wiley'
Publication date
Field of study

core